These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22104997)

  • 41. Embolized Amplatzer septal occluder device presenting with ventricular fibrillation.
    Yuce M; Ozer O; Cakici M; Cine N; Sari I; Davutoglu V
    Cardiovasc Revasc Med; 2011; 12(2):131-2. PubMed ID: 21421193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late surgical retrieval of a nitinol occluder system embolized in the aortic arch.
    Gallo A; Cisico S; Reimers B; Saccà S
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):e63. PubMed ID: 26088587
    [No Abstract]   [Full Text] [Related]  

  • 44. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale.
    Oto A; Aytemir K; Ozkutlu S; Kaya EB; Yorgun H; Canpolat U; Ateş AH; Ozkutlu H
    Echocardiography; 2011 Nov; 28(10):1074-80. PubMed ID: 21967656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early systemic device embolization after transcatheter patent foramen ovale closure.
    Aubry PC; Juliard JM; Brochet E
    J Invasive Cardiol; 2006 Mar; 18(3):E111-3. PubMed ID: 16495605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Migration of an AMPLATZER atrial septal occluder to the abdominal aorta.
    Ferrero E; Ferri M; Viazzo A; Beqaraj F; Gibello L; Berardi G; Santovito D; Nessi F
    Am J Cardiol; 2013 Aug; 112(4):612-3. PubMed ID: 23672986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical rescue of embolized amplatzer devices.
    Amanullah MM; Siddiqui MT; Khan MZ; Atiq MA
    J Card Surg; 2011 May; 26(3):254-8. PubMed ID: 21480992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
    Musto C; Cifarelli A; Fiorilli R; De Felice F; Parma A; Pandolfi C; Confessore P; Bernardi L; Violini R
    J Invasive Cardiol; 2012 Oct; 24(10):510-4. PubMed ID: 23043034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patent foramen ovale closure with the SeptRx device initial experience with the first "In-Tunnel" device.
    Zimmermann WJ; Heinisch C; Majunke N; Staubach S; Russell S; Wunderlich N; Sievert H
    JACC Cardiovasc Interv; 2010 Sep; 3(9):963-7. PubMed ID: 20850097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
    Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subacute endocarditis of an atrial septal closure device in a patient with a patent foramen ovale.
    Krantz SB; Lawton JS
    Ann Thorac Surg; 2014 Nov; 98(5):1821-3. PubMed ID: 25441794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
    J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrieving a large embolised atrial septal occluder - hooked… and landed.
    Goreczny S; Bedair R; Bilska K; Morgan G
    Kardiol Pol; 2017; 75(3):277. PubMed ID: 28326525
    [No Abstract]   [Full Text] [Related]  

  • 57. Percutaneous retrieval of an interatrial septal occluder device embolized into the aortic arch.
    Pala S; Açar G; Tigen K; Kırma C
    Turk Kardiyol Dern Ars; 2010 Oct; 38(7):502-4. PubMed ID: 21206207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Very late patent foramen ovale occluder device embolization.
    Gaspardone A; Giardina A; Gioffrè G; Iamele M; Borioni R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):282-4. PubMed ID: 21386687
    [No Abstract]   [Full Text] [Related]  

  • 59. Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents: initial experiences in Japan.
    Kijima Y; Akagi T; Nakagawa K; Taniguchi M; Ueoka A; Deguchi K; Toh N; Oe H; Kusano K; Sano S; Ito H
    Cardiovasc Interv Ther; 2014 Jan; 29(1):11-7. PubMed ID: 23824518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
    Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.